The utility of preoperative breast magnetic resonance imaging in invasive breast cancer according to HER2 status.

被引：0
|
作者：
McLaughlin, S. A. [1 ]
Vallow, L. A. [1 ]
Hines, S. L. [1 ]
Tan, W. [1 ]
机构：
[1] Mayo Clin, Jacksonville, FL 32224 USA
来源：
CANCER RESEARCH | 2009年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：257S / 257S
页数：1
相关论文
共 50 条
  • [41] Characterization of the HER2 status on circulating breast cancer cells
    Alix-Panabieres, C.
    Riethdorf, S.
    Fehm, T.
    Vendrell, J-P
    Pantel, K.
    CANCER RESEARCH, 2009, 69 (02) : 306S - 306S
  • [42] HER2 STATUS BREAST CANCER IN A POPULATION OF WESTERN ALGERIA
    Zohra, Bekkouche
    Youcef, Gueddouar
    Chahinaize, Zaoui
    Zohra, El Kebir Fatima
    INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH, 2013, 3 (01): : L88 - L93
  • [43] Impact of the Change of the Criteria for HER2 Immunohistochemistry Interpretation on HER2 Status in Breast Cancer
    Harada, Shuko
    Shen, Dejun
    Wei, Shi
    MODERN PATHOLOGY, 2016, 29 : 44A - 44A
  • [44] Standardized Assessment of the HER2 Status in Breast Cancer by Immunohistochemistry
    Hicks, David G.
    LABMEDICINE, 2011, 42 (08): : 459 - 467
  • [45] Impact of the Change of the Criteria for HER2 Immunohistochemistry Interpretation on HER2 Status in Breast Cancer
    Harada, Shuko
    Shen, Dejun
    Wei, Shi
    LABORATORY INVESTIGATION, 2016, 96 : 44A - 44A
  • [46] 2021 update of the GEFPICS' recommendations for HER2 status assessment in invasive breast cancer in France
    Franchet, Camille
    Djerroudi, Lounes
    Maran-Gonzalez, Aurelie
    Abramovici, Olivia
    Antoine, Martine
    Becette, Veronique
    Berghian, Anca
    Blanc-Fournier, Cecile
    Brabencova, Eva
    Charafe-Jauffret, Emmanuelle
    Chenard, Marie-Pierre
    Dauplat, Marie-Melanie
    Delree, Paul
    Duprez-Paumier, Raphaelle
    Fleury, Clemence
    Ghnassia, Jean-Pierre
    Haudebourg, Juliette
    Leroux, Agnes
    MacGrogan, Gaetan
    Mathieu, Marie-Christine
    Michenet, Patrick
    Penault-Llorca, Frederique
    Poulet, Bruno
    Robin, Yves Marie
    Roger, Pascal
    Russ, Elisabeth
    Tixier, Lucie
    Treilleux, Isabelle
    Valent, Alexander
    Verriele, Veronique
    Vincent-Salomon, Anne
    Arnould, Laurent
    Lacroix-Triki, Magali
    ANNALES DE PATHOLOGIE, 2021, 41 (06) : 507 - 520
  • [47] Efficacy of eribulin in patients (pts) with metastatic breast cancer (MBC): A pooled analysis by HER2 and ER status.
    Twelves, Chris
    Cortes, Javier
    Vandat, Linda T.
    Olivo, Martin S.
    He, Yi
    Kaufman, Peter Andrew
    Awada, Ahmad
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [48] HER2 shedding and serum HER2 extracellular domain: Biology and clinical utility in breast cancer
    Tse, Chantal
    Gauchez, Anne-Sophie
    Jacot, William
    Lamy, Pierre-Jean
    CANCER TREATMENT REVIEWS, 2012, 38 (02) : 133 - 142
  • [49] Associations of preoperative breast magnetic resonance imaging with subsequent mastectomy and breast cancer mortality
    Wang, Shi-Yi
    Long, Jessica B.
    Killelea, Brigid K.
    Evans, Suzanne B.
    Roberts, Kenneth B.
    Silber, Andrea L.
    Davidoff, Amy J.
    Sedghi, Tannaz
    Gross, Cary P.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 172 (02) : 453 - 461
  • [50] Disparities in the Use of Preoperative Breast Magnetic Resonance Imaging After Breast Cancer Diagnosis
    Ginzberg, Sara P.
    Grady, Connor B.
    Fayanju, Oluwadamilola M.
    Edmonds, Christine E.
    JCO ONCOLOGY PRACTICE, 2024, 20 (12)
12345